What Is GalaFLEX?
GalaFLEX is a synthetic surgical scaffold made from a bioresorbable polymer called poly-4-hydroxybutyrate (P4HB) that is cleared for use in reinforcing and repairing soft tissue in plastic and reconstructive procedures, including some medically necessary breast surgeries, where extra support may be desired.
The GalaFLEX products are part of a broader family of BD mesh products that include variations like GalaFLEX LITE, GalaFLEX 3D and GalaFLEX 3DR, each designed as a mesh-like support structure to be used alongside sutures where tissue weakness or gaps exist.
In clinical practice, plastic surgeons may elect to use GalaFLEX as an adjunct for patients with compromised or weak breast tissue, including during procedures such as breast revision, mastopexy, or breast augmentation, where additional internal support is considered helpful.
Surgeons sometimes refer to this application as an internal bra technique or internal bra breast lift, because the mesh can provide a temporary scaffold intended to help maintain shape and position while the body heals.
The material is designed to gradually absorb over time, typically within roughly 12 to 18 months, as the body’s own collagen and natural tissue grow into and replace the mesh’s scaffold structure.
Although some surgeons and promotional materials describe potential benefits, the underlying science includes a foreign-body response and integration that varies from patient to patient, and early outcomes do not guarantee long-term results in every case.
FDA communications involving certain mesh products have discussed product labeling, soft-tissue reinforcement indications, and the use of mesh materials in implant-based breast procedures.
Some reports and product information note that implantation can be associated with complications such as infection, seroma, pain, scaffold migration, wound problems, or inflammation, among other potential risks.
Use of mesh materials in breast surgery varies depending on surgeon preference, patient anatomy, reconstructive goals, and clinical judgment.
Because of these factors, independent evaluation of risks, benefits, and long-term outcomes remains an active discussion among plastic surgeons, health care providers and patients considering synthetic mesh for extra support in breast procedures.
How GalaFLEX Is Used in Breast Surgery and Internal Support Techniques
In internal bra surgery, surgeons may place GalaFLEX as an internal support layer to reinforce soft tissue and help stabilize a breast implant during healing.
The scaffold is typically sutured to existing structures so it can provide temporary reinforcement while the body lays down new collagen around the area.
Although GalaFLEX is a synthetic mesh, it is sometimes discussed alongside biologic support options such as an acellular dermal matrix, since both involve implanting additional material to support breast tissue when native tissue alone may not provide enough strength.
The choice between these materials can depend on surgeon preference, patient anatomy, and the specific goals of the procedure.
GalaFLEX is commonly used in the following ways:
- Reinforcing the lower pole to reduce stretch and support implant position
- Creating an internal sling to stabilize a breast implant pocket during revision or reconstruction
- Supporting weakened tissue in mastopexy or augmentation-mastopexy cases
- Providing additional reinforcement in areas where tissue quality is thin or compromised
FDA Communications and Labeling Language on Surgical Mesh in Breast Surgery
FDA communications regarding surgical mesh and acellular dermal matrix (ADM) products are frequently referenced in breast mesh litigation because they discuss product labeling, complication reporting, and published clinical outcome data involving implant-based breast reconstruction procedures.
Some mesh and scaffold products used in breast reconstruction or internal support procedures are cleared for soft-tissue reinforcement indications.
FDA communications issued in 2021 and 2023 addressed how certain mesh and ADM products have been used in implant-based reconstruction settings and discussed available data involving postoperative outcomes such as infection, reoperation, implant loss, and revision surgery.
These FDA communications do not determine whether a particular patient’s complications were caused by a specific product.
Instead, they provide regulatory and clinical context that may later be compared with operative reports, complication timelines, revision history, pathology findings, and other medical evidence when evaluating a claim.
FDA discussions involving “labeling updates” for certain BD mesh products referred to revisions in product warnings, precautions, and instructions for use. The communications did not announce a product recall or market withdrawal.
FDA communications and related notices:
- FDA “In Brief” (March 31, 2021): ADM products used in implant-based breast reconstruction differ in complication rates:FDA communication discussing differing complication outcomes reported among certain ADM products used in implant-based breast reconstruction procedures.
- FDA GovDelivery bulletin (April 2021): Safety Communication distribution to patients/caregivers/health care providers:Distribution notice related to the FDA’s safety communication involving ADM products and implant-based breast reconstruction outcomes.
- FDA Letter to Health Care Providers (Nov. 9, 2023): Labeling updates for BD mesh products: FDA communication regarding labeling updates for certain BD mesh products used for soft-tissue reinforcement applications.
- FDA GovDelivery bulletin (Nov. 2023): Labeling updates summary: Bulletin summarizing the FDA’s communication regarding labeling updates for certain BD mesh products.
- FDA patient guidance page: “Breast Implant Surgery” (ongoing guidance): FDA patient resource discussing implant-based breast surgery, possible complications, reoperation considerations, and questions patients may wish to discuss with their surgeons before surgery.
Potential Complications Following Breast Surgery Involving Mesh or Scaffolds
Breast surgery involving mesh or scaffold materials is intended to provide additional structural support in situations where reinforcement of soft tissue may be considered beneficial during reconstruction, revision, or augmentation procedures.
Healing outcomes can vary from patient to patient, and some individuals experience postoperative complications that require additional treatment, monitoring, or revision surgery.
Early postoperative complications may include fluid collections, wound-healing problems, infection, inflammation, or changes involving the implant pocket and surrounding tissue.
In some cases, scar tissue formation or healing changes may affect breast shape, implant position, firmness, or long-term comfort.
Some patients also report chronic pain, nerve-related symptoms, tightness, or sensitivity following reconstruction or augmentation procedures, particularly when scar tissue, swelling, or inflammation affects nearby nerves or soft tissue structures.
These outcomes are typically evaluated based on the patient’s medical history, timing of symptoms, operative findings, postoperative course, imaging when available, and the documented treatment required to address complications.
Reported complications following breast surgery involving mesh or scaffold materials may include:
- Surgical site infection or deep infection involving the implant pocket
- Seroma or persistent fluid buildup requiring aspiration or additional drains
- Delayed wound healing, wound dehiscence, or incision breakdown
- Tissue damage involving thin skin flaps or compromised circulation
- Tissue necrosis requiring debridement or additional wound care
- Mesh migration or shifting of implanted support material
- Implant malposition, asymmetry, or contour irregularities
- Capsular contracture, including painful tightening or breast firmness
- Chronic pain, nerve-related symptoms, numbness, burning, or hypersensitivity
- Implant exposure, mesh exposure, or tissue erosion
- Revision surgery, implant exchange, or implant removal
Not every complication following breast surgery is caused by the mesh itself, and implant-based breast procedures may involve recognized risks even when no mesh material is used.
In many cases, the clinical question is whether the patient’s postoperative course remained within the range of expected healing or whether complications progressed in a way that required repeated intervention, revision surgery, or prolonged treatment.
Operative reports, follow-up records, imaging studies, pathology findings, and revision surgery documentation often provide the clearest timeline when evaluating postoperative complications and related treatment needs.
When a Post-Surgical Complication Becomes a Legal Claim
Many patients experience some pain, swelling, bruising, or healing delays after breast reconstruction or augmentation surgery, and those outcomes alone do not automatically establish a product-related claim.
Legal review is more likely when complications become severe, persistent, medically significant, or require additional procedures such as washout surgery, implant revision, mesh removal, or implant removal.
These reviews generally focus on information that can be verified through medical records, including the product used, operative technique, timing of symptoms, complication history, and the treatment required after surgery.
Product identification is often important because operative reports, implant logs, device labels, or billing records may help confirm the specific mesh or scaffold material involved in the procedure.
Timing may also become relevant when evaluating whether complications developed shortly after implantation or later in connection with infection, wound breakdown, trauma, revision surgery, or other postoperative events.
When attorneys review these cases, the analysis typically focuses on documented medical evidence, treatment history, measurable damages, and whether the available records support the allegations being investigated.
Do You Qualify for a GalaFLEX-Related Claim Review?
A GalaFLEX-related claim review generally begins with two questions: whether GalaFLEX or another mesh product was used during the procedure, and whether the patient later experienced complications that required additional medical treatment, revision surgery, or implant-related intervention.
Breast mesh lawsuits often involve allegations concerning postoperative complications, product labeling, informed consent, complication reporting, and the use of mesh materials in implant-based breast procedures.
Manufacturers named in litigation dispute allegations that their products were defective or improperly marketed.
In practice, claim reviews commonly focus on documented complications such as infection, wound-healing problems, chronic pain, capsular contracture, implant malposition, fluid collections, mesh exposure, cosmetic deformity, or repeated revision procedures following surgery.
Product identification is often an important part of the review process.
Operative reports, implant logs, device labels, Unique Device Identifier (UDI) information, pathology findings, and revision surgery records may help confirm whether GalaFLEX or another mesh product was used.
The timing and progression of symptoms may also become relevant when evaluating whether complications developed shortly after surgery or later in connection with infection, wound breakdown, tissue changes, implant-position problems, or other postoperative events.
Even when complications are significant, eligibility for a legal claim depends on the available medical documentation, the patient’s treatment history, product identification records, and the specific allegations being investigated.
Speaking with a licensed attorney may help patients better understand whether their surgical history, medical records, and documented complications warrant further legal review.
Gathering Evidence for a GalaFLEX Breast Mesh Claim
To start an internal bra mesh claim, you’ll need to gather evidence that shows what product was implanted, when symptoms began, and what medical care followed.
Product identification often depends on surgical records, and you can sometimes confirm the mesh by locating device stickers, a Unique Device Identifier (UDI), and the device lot number in your chart.
Evidence also matters because you may still have a claim even if your symptoms appeared years later, as long as the timeline and medical documentation support what happened.
If you undergo revision surgery, you should not discard removed mesh material, since it can serve as evidence in your case.
Evidence that may be important includes:
- Operative reports and surgeon notes describing the mesh placement and the purpose of the internal support
- Implant logs, device stickers, UDI information, and device lot or catalog numbers
- Hospital and clinic follow-up notes documenting symptoms, complications, and treatment decisions
- Imaging records, when used to evaluate fluid collections, implant position, or suspected complications
- Lab results and culture reports if infection was suspected or confirmed
- Revision or removal surgery records, including pathology or explant documentation
- The removed mesh material itself, if it was explanted, preserved, and documented through the facility chain of custody
- Itemized medical bills and insurance statements showing costs of treatment and repeat procedures
- Employment and wage records showing time missed from work or reduced earning capacity
- A personal timeline of symptoms and key treatment events to align with the medical chart
Your lawyer can tell you exactly what evidence you will need for your individual claim, based on your surgery history and complications.
If you are missing records, hospitals and surgical centers often maintain implant documentation that can be requested directly.
Acting sooner rather than later can matter because statutes of limitations vary, and preserving medical records and any removed material is easier closer to the time of treatment.
Potential Damages in Breast Mesh Claims
Damages are the losses a person claims after an injury, and they can include both financial costs and the personal impact of the complications.
Patients who experienced complications from an Internal Bra System may be entitled to compensation, depending on the medical evidence and the circumstances of the procedure.
Potential compensation in an internal bra lawsuit may include economic and non-economic damages, which are evaluated based on documentation rather than assumptions.
Lawyers typically perform a comprehensive review of medical records, billing statements, employment documentation, and the treatment timeline to assess what the complications cost and how they changed the person’s day-to-day life.
The goal is to present damages in a clear, provable way that matches the severity of the injuries and the long-term impact.
Damages may include:
- Past medical expenses, including hospital care, antibiotics, imaging, and wound treatment
- Future medical care costs, including revision surgery, implant exchange, or implant removal
- Costs related to reconstruction changes, staged procedures, and follow-up appointments
- Lost wages and reduced earning capacity from missed work or lasting limitations
- Physical pain and ongoing symptoms, including chronic pain
- Emotional harm, including anxiety, depression, or distress related to complications and body changes
- Scarring, tissue loss, and permanent disfigurement
- Out-of-pocket expenses such as prescriptions, medical supplies, travel, and caregiving needs
- Loss of enjoyment of life and reduced ability to participate in normal activities
TorHoerman Law: Reviewing Breast Mesh Claims Involving GalaFLEX
Breast mesh claims involving GalaFLEX often depend on careful review of surgical records, complication timelines, and the medical treatment required after implantation.
When recovery deviates from what would typically be expected and leads to repeated procedures, prolonged pain, or lasting changes, the details matter.
TorHoerman Law reviews these cases by focusing on documentation, product identification, and how the complication history affected the patient’s health and quality of life.
If you believe a GalaFLEX mesh or internal bra procedure contributed to serious complications, TorHoerman Law can evaluate your records and explain whether your circumstances may support a claim.
Contact TorHoerman Law to request a confidential case review and learn what next steps may be available.
